KLCM Advisors Inc. Grows Stock Holdings in The Clorox Company $CLX

KLCM Advisors Inc. grew its holdings in The Clorox Company (NYSE:CLX) by 43.4% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 18,230 shares of the company’s stock after acquiring an additional 5,515 shares during the period. KLCM Advisors Inc.’s holdings in Clorox were worth $1,889,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after acquiring an additional 514 shares during the last quarter. Woodline Partners LP raised its holdings in Clorox by 253.7% during the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares during the period. Baird Financial Group Inc. lifted its position in Clorox by 1.7% in the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after buying an additional 424 shares during the last quarter. Jump Financial LLC boosted its stake in Clorox by 173.5% during the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after buying an additional 7,924 shares during the period. Finally, Bank of Nova Scotia boosted its stake in Clorox by 26.2% during the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after buying an additional 3,352 shares during the period. Institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on CLX shares. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. Morgan Stanley dropped their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. JPMorgan Chase & Co. reduced their target price on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. TD Cowen lifted their target price on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Finally, Wells Fargo & Company lowered their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research note on Monday, May 18th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce” and a consensus target price of $103.40.

Clorox Stock Up 3.8%

Shares of Clorox stock traded up $3.50 during trading on Friday, hitting $96.57. 2,188,531 shares of the stock traded hands, compared to its average volume of 2,152,430. The firm has a market cap of $11.68 billion, a P/E ratio of 15.68, a price-to-earnings-growth ratio of 0.44 and a beta of 0.54. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The stock’s fifty day simple moving average is $94.10 and its 200 day simple moving average is $104.07.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the previous year, the company posted $1.45 earnings per share. The firm’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities analysts predict that The Clorox Company will post 5.53 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.